NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression
LI Ruixiao 1 , TANG Qisheng 1 , MA Shanjin 1 , ZHANG Bo 1 , LI Xuelian 2 , ZHANG Zhiming 1
1. Department of Urology, Tangdu Hospital, the Air Force Medical University, Xi'an 710038, Shaanxi Province, China; 2. Department of Surgery, Xi'an Hospital of Traditional Chinese Medicine, Xi'an 710002, Shaanxi Province, China
LI Ruixiao , TANG Qisheng , MA Shanjin , ZHANG Bo , LI Xuelian , ZHANG Zhiming . NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression[J]. China Oncology, 2021, 31(4): 263-267.